N,N'-dicyclohexyl-4-morpholinecarboxamidine

HCID 21079CAS 4975-73-9

Basic information

Standard SMILES
C1CCC(N=C(NC2CCCCC2)N2CCOCC2)CC1
InChIKey
OZNYZQOTXQSUJM-UHFFFAOYSA-N
Molecular formula
C17H31N3O
Average molar mass
293.4 g/mol
Monoisotopic mass
293.24671262

Names & identifiers

Preferred name
N,N'-dicyclohexyl-4-morpholinecarboxamidine
IUPAC
N,N'-dicyclohexylmorpholine-4-carboximidamide
English name
N,N'-Dicyclohexyl-4-morpholinecarboxamidine
Molecular formula
C17H31N3O
Molecular weight
293.45

Names & synonyms

4975-73-9N,N'-Dicyclohexyl-4-morpholinecarboxamidine4-Morpholinecarboximidamide, N,N'-dicyclohexyl-DTXSID60198013U-18177RefChem:821890DTXCID90120504225-622-1N,N'-dicyclohexylmorpholine-4-carboximidamideN,N'-Dicyclohexyl-4-morpholine carboxamidineN,N'-Dicyclohexylmorpholine-4-carboxamidineC17H31N3O
Show more names
u18177N,N′-Dicyclohexyl-4-Cefalexin Impurity 27LABOTEST-BB LT001595964-(N,NDICYCLOHEXYLAMIDINO)MORPHOLINEDicyclohexyl-4-morpholinecarboxamidinen,n’-dicyclohexyl-1-morpholinoformamidinen,n’-dicyclohexyl-1-morpholino-formamidin4-Morpholino-N,N'-dicyclohexylcarboxamidine
MFCD00063252(Z)-N,N'-dicyclohexylmorpholine-4-carboximidamideN,N'-Dicyclohexyl-1-morpholinoformamidineN,N'-Dicyclohexyl-morpholine-4-carboxamidineFORMAMIDINE, N,N'-DICYCLOHEXYL-1-MORPHOLINO-NSC671971351753-99-54-Morpholinecarboximidamide,N'-dicyclohexyl-

Database identifiers

CAS
4975-73-9
PubChem CID
21079
DTXSID
DTXSID60198013
ChEMBL
CHEMBL123456
EC Number
225-622-1
Nikkaji
J24.472D

Properties

Computed structural properties

XLogP
2.9
Topological polar surface area
36.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
4
Heavy atoms
21

Physicochemical properties

Melting point
105 · 105-107 °C(lit.)
Boiling point
423.2 · 423.2±55.0 °C(Predicted)
Density
1.18 · 1.18±0.1 g/cm3(Predicted)
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
solubility
soluble in Methanol
form
powder to crystal

Safety & regulation

GHS classification

GHS Classification · 5 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 68 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Hazard information

Hazard Classes and CategoriesSkin Irrit. 2 (100%);Eye Irrit. 2 (100%);STOT SE 3 (100%)

Safety data

wgk
3
rtecs
LQ4566500
hs_code
29349990
risk_code
36/37/38
Signal word
Warning
Symbol(GHS)
GHS07

Chemistry & industry

Applications

UsesN,N′-Dicyclohexyl-4-morpholinecarboxamidine was used as reagent in the synthesis of alkoxyalkyl analogs of nucleotide phosphonates, cidofovir and cyclic cidofovir.

General DescriptionN,N′-Dicyclohexyl-4-morpholinecarboxamidine is kidney-selective ATP-sensitive potassium blocker. It is an an orally effective nonkaliuretic diuretic in rats.

Preparation methods

PreparationN,N'-Dicyclohexyl-4-morpholinecarboxamidine is easily prepared by refluxing morpholine and 1,3-Dicyclohexylcarbodiimide.

Upstream & downstream products

Suppliers50 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
湖北蝶化新材料科技有限公司86-18372897-544 18995560451
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
郑州阿尔法化工有限公司+86-18530059196 · [email protected]

Related reactions

3 records

Linked notes

Loading…